Protection product sales in Q1 2017 rose by 6.6% (£8.7 million) to £140.2 million, returning to the peak levels of 2016, according to analysis from Equifax Touchstone shared exclusively with COVER.
The data, which is collated from 22 protection providers, with input from more than 11,000 advisers, revealed that decreasing term with critical illness policies grew most during the quarter, up by 15.9% on Q4 2016 to £13.5 million. This was closely followed by term policies which witnessed a 14.4% (£7.5 million) increase. Meanwhile critical illness, whole of life and relevant life policies all performed favourably, with sales increasing by 4.3% (£0.2 million), 2.6% (£0.2 million) and 1.8% (£0.05 million) respectively. Three policy types saw drops in sales, with income protection s...
To continue reading this article...
Join COVER for free
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.